Becton, Dickinson (BDX) | Financial Analysis & Statements

Becton, Dickinson and Company | Large-cap | Healthcare

$176.16

-0.63%

Becton, Dickinson vs Intuitive Surgical Becton, Dickinson vs Alcon Becton, Dickinson vs ResMed Becton, Dickinson vs West Pharmaceutical Becton, Dickinson vs Baxter International Becton, Dickinson vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 20.2B

Gross Profit 9.1B 45.22%

Operating Income 2.9B 14.15%

Net Income 1.7B 8.45%

EPS (Diluted) $5.86

Balance Sheet Metrics

Total Assets 57.3B

Total Liabilities 31.4B

Shareholders Equity 25.9B

Debt to Equity 1.21

Cash Flow Metrics

Operating Cash Flow 3.9B

Free Cash Flow 3.1B

Revenue & Profitability Trend

Becton, Dickinson Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	20.2B	19.4B	18.9B	19.1B	16.1B
Cost of Goods Sold	11.1B	11.2B	10.4B	10.5B	9.3B
Gross Profit	9.1B	8.2B	8.5B	8.6B	6.8B
Operating Expenses	6.3B	5.7B	6.0B	6.2B	5.6B
Operating Income	2.9B	2.4B	2.5B	2.4B	1.2B
Pre-tax Income	2.0B	1.7B	1.8B	1.7B	414.0M
Income Tax	300.0M	132.0M	148.0M	88.0M	62.0M
Net Income	1.7B	1.5B	1.8B	2.1B	874.0M
EPS (Diluted)	$5.86	$4.94	$5.88	$6.85	$2.71

Income Statement Trend

Becton, Dickinson Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	10.5B	8.7B	8.1B	8.8B	9.0B
Non-Current Assets	46.8B	44.1B	44.8B	45.0B	45.0B
Total Assets	57.3B	52.8B	52.9B	53.9B	54.0B
Liabilities
Current Liabilities	9.0B	6.6B	7.8B	6.6B	5.8B
Non-Current Liabilities	22.4B	20.3B	19.8B	23.6B	24.4B
Total Liabilities	31.4B	27.0B	27.7B	30.2B	30.2B
Equity
Total Shareholders Equity	25.9B	25.8B	25.3B	23.7B	23.8B

Balance Sheet Composition

Becton, Dickinson Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	1.7B	1.5B	1.6B	1.6B	352.0M
Operating Cash Flow	3.9B	3.0B	3.0B	4.2B	2.7B
Investing Activities
Capital Expenditures	-	-	-	-	-
Investing Cash Flow	-4.8B	158.0M	-2.2B	-649.0M	-421.0M
Financing Activities
Dividends Paid	-1.1B	-1.1B	-1.1B	-1.0B	-1.0B
Financing Cash Flow	2.6B	-2.0B	-736.0M	-3.3B	22.0M
Free Cash Flow	3.1B	2.1B	1.7B	3.5B	2.8B

Cash Flow Trend

Becton, Dickinson Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 32.89

Forward P/E 10.79

Price to Book 1.93

Price to Sales 2.33

PEG Ratio 10.79

Profitability Ratios

Profit Margin 7.18%

Operating Margin 16.01%

Return on Equity 5.89%

Return on Assets 3.69%

Financial Health

Current Ratio 1.13

Debt to Equity 76.34

Beta 0.28

Per Share Data

EPS (TTM) $5.16

Book Value per Share $88.07

Revenue per Share $72.21

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
bdx	48.6B	32.89	1.93	5.89%	7.18%	76.34
Intuitive Surgical	184.6B	75.42	10.79	15.96%	28.41%	0.00
Alcon	42.8B	38.45	1.95	5.23%	11.28%	23.63
ResMed	37.3B	28.60	6.73	25.81%	26.15%	15.14
West Pharmaceutical	16.0B	34.96	5.96	17.42%	16.13%	11.46
Baxter International	15.4B	133.76	2.17	-3.51%	-5.20%	146.14

Financial data is updated regularly. All figures are in the company's reporting currency.